Cancer Drugs Fund Application and Approval Rates Continue to Rise
The Rarer Cancers Foundation (RCF) has published the latest quarterly briefings on the operation of the Cancer Drugs Fund (CDF) at strategic health authority (SHA) level for July to September 2011.
These follow the first set of briefings produced for the period for April to June 2011 and build on our report Funding Cancer Drugs: An evaluation of the impact of policies to improve access to cancer treatments published in June 2011.
Key findings for July to September are:
The provision of timely and accurate data on use of the CDF is important in enabling SHAs to manage the allocation of funding, demonstrate that the funding is being used in line with regional arrangements and improve the evidence on how these drugs perform in real-world clinical practice.
The RCF is committed to ensuring that healthcare professionals, patients and the public are able to access information about how the CDF is being used in each SHA and we will, therefore, be publishing these SHA level bulletins on a quarterly basis, data permitting.
Please find details on the use of the CDF in your local area below: